MedWand®'s Latest Regulatory Green Light Enables Use of the Sensor Based Medical Device for Comprehensive Patient Assessment Internationally

RANCHO SANTA MARGARITA, Calif. - EntSun -- MedWand Solutions, Inc., the ultimate healthcare solution and a pioneer in telehealth technology, is pleased to announce its recent regulatory clearance in Thailand. This latest approval allows MedWand to empower a broader spectrum of clinicians and healthcare providers, enabling them to elevate care standards and grant easier access to healthcare services.

"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."

More on EntSun News

• P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
• DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
• Antoine Morgan steps into the "MARRIAGE BOX" and Things are getting interesting!
• French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
• LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood

MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.

"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.

More on EntSun News

• Don Barnhart Brings His NFTG Tour Home as Delirious Celebrates One Year at Silver Sevens
• Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
• Suits & Shoot Returns for 3rd Annual Noir Affair
• 'The Last Howl' Documentary Advocates for Conservation and Wildlife Preservation
• Venice FF 2026, Samantha Casella screens The Serpent's Caress

The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.

For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.

*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.